Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001415889-25-007997

CHIEF FINANCIAL OFFICER gave up 29,843 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Alam Kamran CHIEF FINANCIAL OFFICER 2025-03-11 Shares withheld for taxes −29,843 $1.69 $50,435 1,242,094 D
Loading xslF345X05/form4-03132025_040301.xml…